Search

Search Constraints

You searched for: Author/Creator Box, G.

Search Results

2. Discovery and validation of biomarkers to support clinical development of NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor. (October 2022)

3. Improved binding affinity and pharmacokinetics enables sustained degradation of BCL6 in vivo. (October 2022)